1. Academic Validation
  2. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

  • Cell. 1995 Jun 16;81(6):935-46. doi: 10.1016/0092-8674(95)90013-6.
G H Fisher 1 F J Rosenberg S E Straus J K Dale L A Middleton A Y Lin W Strober M J Lenardo J M Puck
Affiliations

Affiliation

  • 1 Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-4470, USA.
Abstract

Five unrelated children are described with a rare autoimmune lymphoproliferative syndrome (ALPS) characterized by massive nonmalignant lymphadenopathy, autoimmune phenomena, and expanded populations of TCR-CD3+CD4-CD8- lymphocytes. These findings, suggesting a genetic defect in the ability of T lymphocytes to respond to normal immunoregulatory mechanisms, prompted an evaluation of lymphocyte Apoptosis. Each child had defective Fas-mediated T lymphocyte Apoptosis associated with a unique, deleterious Fas gene mutation. One mutation appeared to cause a simple loss of function; however, four Others had a dominant negative phenotype when coexpressed with normal Fas. Family studies demonstrated the inheritance of the mutant Fas alleles. The occurrence of Fas mutations together with abnormal T cell Apoptosis in ALPS patients suggests an involvement of Fas in this recently recognized disorder of lymphocyte homeostasis and peripheral self-tolerance.

Figures